STEK logo

Stemtech Corporation Stock Price

OTCPK:STEK Community·US$819.4k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

STEK Share Price Performance

US$0.0044
-0.03 (-87.93%)
US$0.0044
-0.03 (-87.93%)
Price US$0.0044

STEK Community Narratives

There are no narratives available yet.

Snowflake Analysis

Medium-low risk and slightly overvalued.

6 Risks
1 Reward

Stemtech Corporation Key Details

US$3.9m

Revenue

US$942.5k

Cost of Revenue

US$3.0m

Gross Profit

US$6.3m

Other Expenses

-US$3.3m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.02
75.90%
-84.86%
-77.5%
View Full Analysis

About STEK

Founded
2005
Employees
n/a
CEO
Charles Arnold
WebsiteView website
www.stemtech.com

Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. The company’s products enhance and support the work of the body’s stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. It offers rapid renew stem cell peptide night cream under the RCM System, stemrelease3, Stemflo MigraStem, OraStem, and Collect One brand name, as well as Cellect One shield hypochlorous acid skin care product. It serves through independent distributors Stemtech Corporation was founded in 2005 and is headquartered in Naples, Florida.

Recent STEK News & Updates

Recent updates

No updates